Krystexxa

Amgen's new Horizon products bolster top line despite continued Tepezza struggles
Fierce Pharma
Fri, 05/3/24 - 11:23 am
Amgen
Horizon Pharma
Krystexxa
Tepezza
Selecta, Sobi rout gout in pair of phase 3 trials that could challenge Horizon
Fierce Biotech
Tue, 03/21/23 - 10:00 am
Sobi
Selecta Biosciences
gout
SEL-212
Horizon Therapeutics
Krystexxa
Krystexxa Chronic Gout Medication Gets Expanded FDA Approval
Xtalks
Thu, 07/14/22 - 07:53 pm
Horizon Therapeutics
Krystexxa
gout
FDA
Orphan drug specialist Horizon looks to double down on its gout expertise with acquired rights to Arrowhead's RNAi med
Endpoints
Mon, 06/21/21 - 11:02 am
Horizon Therapeutics
gout
Krystexxa
Arrowhead Pharmaceuticals
ARO-XDH
Horizon Therapeutics initiates MIRROR trial evaluating KRYSTEXXA in combination with methotrexate
Pharmaceutical Business Review
Fri, 06/21/19 - 10:06 am
Horizon Therapeutics
clinical trials
uncontrolled gout
gout
Krystexxa
Krystexxa shows signs of life as Horizon keeps pushing sales force expansion
Fierce Pharma
Wed, 10/11/17 - 11:20 am
Krystexxa
Horizon Pharma
drug reps
gout
Aiming for $250M in sales, Horizon quadruples force behind gout med Krystexxa
Fierce Pharma Marketing
Mon, 01/25/16 - 11:13 am
drug reps
Horizon Pharma
Krystexxa
gout
Savient attracts a buyer willing to get it out of bankruptcy court
Fierce Pharma
Wed, 12/11/13 - 02:46 pm
Savient
M&A
Krystexxa
Crealta Pharmaceuticals
Savient Pharmaceuticals: Is Anything Left?
Seeking Alpha
Tue, 03/26/13 - 10:29 am
Krystexxa
Savient
gout
10 top drug launch disasters
Fierce Pharma
Wed, 11/28/12 - 11:13 am
drug launches
Rare Disease Therapeutics
Anascorp
AstraZeneca
Brilinta
Somaxon
Silenor
Sanofi
Multaq
Savient
Krystexxa
XenoPort
Horizant
Human Genome Sciences
Benlysta
Zaltrap
Dendreon
Provenge
KV Pharmaceutical
Makena
Savient Pharma: Still Struggling To Grow KRYSTEXXA Sales
Seeking Alpha
Wed, 11/21/12 - 10:44 am
Savient
Krystexxa
gout
Savient Receives Positive CHMP Opinion for Krystexxa Approval in the EU
Equities.com
Sat, 10/20/12 - 10:54 am
Krystexxa
Savient
gout
Savient's Krystexxa: How I Get A $209 Million Sales Estimate By 2015
Seeking Alpha
Thu, 12/8/11 - 11:33 am
Savient
gout
Krystexxa
Savient Pharmaceuticals: The Potential Role Of Krystexxa The Treatment Of Gout
Seeking Alpha
Sat, 12/3/11 - 11:06 am
Savi
Krystexxa
gout
Savient Pharmaceuticals: Sluggish Launch Of Krystexxa Presents Buying Opportunity
Seeking Alpha
Wed, 11/30/11 - 05:29 pm
Krystexxa
Savient
gout
Savient falls after analyst downgrades stock, expecting lower sales of its gout drug Krystexxa
Yahoo/AP
Fri, 11/11/11 - 09:50 am
Savient
gout
Krystexxa
Savient Pharmaceuticals Announces New Data Surrounding KRYSTEXXA® and the Impact of Refractory Chronic Gout at the American College of Rheumatology Meeting
Yahoo/PR NewsWire
Sat, 11/5/11 - 02:49 pm
Savient
Krystexxa
gout
New Medicare code could boost Krystexxa sales
Fierce Pharma
Fri, 11/4/11 - 12:19 pm
Medicare
Krystexxa
gout
Savient
Savient Pharma: Cheap Biotech Without FDA Approval Risk
Seeking Alpha
Tue, 04/26/11 - 06:18 am
Savient
gout
Krystexxa
Savient Reports Batch Failures With New Gout Medicine
Bloomberg
Fri, 01/7/11 - 10:34 am
Savient
gout
Krystexxa

Pages